Literature DB >> 18385134

ATP-binding cassette A1-mediated lipidation of apolipoprotein A-I occurs at the plasma membrane and not in the endocytic compartments.

Maxime Denis1, Yves D Landry, Xiaohui Zha.   

Abstract

ATP-binding cassette transporter (ABC) A1 is required for the lipidation of apolipoprotein A-I to generate high density lipoprotein (HDL). This process is proposed to occur through a retro-endocytosis pathway in which apoA-I internalizes with ABCA1 and generates HDL from the endosomal compartments before resecretion. The aim of this study was to determine the route of apoA-I endocytosis and whether endocytosis contributes to HDL biogenesis. Using confocal microscopy, we found that internalized apoA-I only transiently colocalized with transferrin, a retro-endocytosis marker. Instead, apoA-I perfectly colocalized with a bulk phase uptake marker (fluorescein isothiocyanate-dextran) and, at later time points, with LysoTracker in several cell models including macrophages, fibroblasts, and baby hamster kidney cells. ABCA1 colocalized poorly with internalized apoA-I. To determine the contribution of internalized apoA-I to HDL biogenesis, we specifically removed apoA-I from the cell surface and analyzed the fate of internalized apoA-I. We found that 23% of cell-associated apoA-I was internalized at steady state. Of internalized apoA-I, only 20% was converted to HDL, and the rest was degraded, consistent with a lysosomal destination. We also found that apoA-I was released approximately five times faster from the plasma membrane than from the intracellular compartments. From these kinetic parameters, we estimated that approximately 5.6% of apoA-I that interacts with cells is degraded and that internalized apoA-I contributes to approximately 1.4% of total HDL production. We also found that blocking endocytosis with sucrose or cytochalasin D did not decrease cholesterol efflux or HDL biogenesis. We therefore conclude that the plasma membrane is the main platform where ABCA1-mediated lipidation of apoA-I occurs.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18385134      PMCID: PMC3259641          DOI: 10.1074/jbc.M709597200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  33 in total

1.  Transport of lipids from golgi to plasma membrane is defective in tangier disease patients and Abc1-deficient mice.

Authors:  E Orsó; C Broccardo; W E Kaminski; A Böttcher; G Liebisch; W Drobnik; A Götz; O Chambenoit; W Diederich; T Langmann; T Spruss; M F Luciani; G Rothe; K J Lackner; G Chimini; G Schmitz
Journal:  Nat Genet       Date:  2000-02       Impact factor: 38.330

Review 2.  Dissecting virus entry via endocytosis.

Authors:  Sara B Sieczkarski; Gary R Whittaker
Journal:  J Gen Virol       Date:  2002-07       Impact factor: 3.891

Review 3.  A receptor-mediated pathway for cholesterol homeostasis.

Authors:  M S Brown; J L Goldstein
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

4.  ABCA1 redistributes membrane cholesterol independent of apolipoprotein interactions.

Authors:  Ashley M Vaughan; John F Oram
Journal:  J Lipid Res       Date:  2003-04-16       Impact factor: 5.922

5.  Endocytosis is enhanced in Tangier fibroblasts: possible role of ATP-binding cassette protein A1 in endosomal vesicular transport.

Authors:  X Zha; J Genest; R McPherson
Journal:  J Biol Chem       Date:  2001-08-14       Impact factor: 5.157

6.  The lipidation by hepatocytes of human apolipoprotein A-I occurs by both ABCA1-dependent and -independent pathways.

Authors:  Robert S Kiss; Dan C McManus; Vivian Franklin; Wei Ling Tan; Andrea McKenzie; Giovanna Chimini; Yves L Marcel
Journal:  J Biol Chem       Date:  2003-01-22       Impact factor: 5.157

7.  A PEST sequence in ABCA1 regulates degradation by calpain protease and stabilization of ABCA1 by apoA-I.

Authors:  Nan Wang; Wengen Chen; Patrick Linsel-Nitschke; Laurent O Martinez; Birgit Agerholm-Larsen; David L Silver; Alan R Tall
Journal:  J Clin Invest       Date:  2003-01       Impact factor: 14.808

8.  Naturally occurring mutations in the largest extracellular loops of ABCA1 can disrupt its direct interaction with apolipoprotein A-I.

Authors:  Michael L Fitzgerald; Andrea L Morris; Jeongmi S Rhee; Lorna P Andersson; Armando J Mendez; Mason W Freeman
Journal:  J Biol Chem       Date:  2002-06-25       Impact factor: 5.157

9.  The ABCA1 transporter modulates late endocytic trafficking: insights from the correction of the genetic defect in Tangier disease.

Authors:  Edward B Neufeld; John A Stonik; Stephen J Demosky; Catherine L Knapper; Christian A Combs; Adele Cooney; Marcella Comly; Nancy Dwyer; Joan Blanchette-Mackie; Alan T Remaley; Silvia Santamarina-Fojo; H Bryan Brewer
Journal:  J Biol Chem       Date:  2004-01-27       Impact factor: 5.157

10.  Apolipoprotein A-I but not high-density lipoproteins are internalised by RAW macrophages: roles of ATP-binding cassette transporter A1 and scavenger receptor BI.

Authors:  Iris Lorenzi; Arnold von Eckardstein; Clara Cavelier; Silvija Radosavljevic; Lucia Rohrer
Journal:  J Mol Med (Berl)       Date:  2007-10-01       Impact factor: 4.599

View more
  43 in total

1.  Reducible DNA nanoparticles enhance in vitro gene transfer via an extracellular mechanism.

Authors:  Wenchao Sun; Pamela B Davis
Journal:  J Control Release       Date:  2010-05-12       Impact factor: 9.776

Review 2.  Hepatic ABCA1 and VLDL triglyceride production.

Authors:  Mingxia Liu; Soonkyu Chung; Gregory S Shelness; John S Parks
Journal:  Biochim Biophys Acta       Date:  2011-10-06

Review 3.  The interaction of ApoA-I and ABCA1 triggers signal transduction pathways to mediate efflux of cellular lipids.

Authors:  Guo-Jun Zhao; Kai Yin; Yu-Chang Fu; Chao-Ke Tang
Journal:  Mol Med       Date:  2012-03-27       Impact factor: 6.354

4.  Cytoskeleton disruption in J774 macrophages: consequences for lipid droplet formation and cholesterol flux.

Authors:  Ginny L Weibel; Michelle R Joshi; W Gray Jerome; Sandra R Bates; Kevin J Yu; Michael C Phillips; George H Rothblat
Journal:  Biochim Biophys Acta       Date:  2011-10-08

5.  SPTLC1 binds ABCA1 to negatively regulate trafficking and cholesterol efflux activity of the transporter.

Authors:  Norimasa Tamehiro; Suiping Zhou; Keiichiro Okuhira; Yair Benita; Cari E Brown; Debbie Z Zhuang; Eicke Latz; Thorsten Hornemann; Arnold von Eckardstein; Ramnik J Xavier; Mason W Freeman; Michael L Fitzgerald
Journal:  Biochemistry       Date:  2008-05-17       Impact factor: 3.162

Review 6.  Is ABCA1 a lipid transfer protein?

Authors:  Michael C Phillips
Journal:  J Lipid Res       Date:  2018-01-05       Impact factor: 5.922

7.  Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution.

Authors:  Charulatha Vedhachalam; Palaniappan Sevugan Chetty; Margaret Nickel; Padmaja Dhanasekaran; Sissel Lund-Katz; George H Rothblat; Michael C Phillips
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

8.  Small GTPase ARF6 Regulates Endocytic Pathway Leading to Degradation of ATP-Binding Cassette Transporter A1.

Authors:  Nigora Mukhamedova; Anh Hoang; Huanhuan L Cui; Irena Carmichael; Ying Fu; Michael Bukrinsky; Dmitri Sviridov
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-10-06       Impact factor: 8.311

9.  V-ATPase (Vacuolar ATPase) Activity Required for ABCA1 (ATP-Binding Cassette Protein A1)-Mediated Cholesterol Efflux.

Authors:  Shuhui Wang Lorkowski; Gregory Brubaker; Kailash Gulshan; Jonathan D Smith
Journal:  Arterioscler Thromb Vasc Biol       Date:  2018-11       Impact factor: 8.311

10.  Initial interaction of apoA-I with ABCA1 impacts in vivo metabolic fate of nascent HDL.

Authors:  Anny Mulya; Ji-Young Lee; Abraham K Gebre; Elena Y Boudyguina; Soon-Kyu Chung; Thomas L Smith; Perry L Colvin; Xian-Cheng Jiang; John S Parks
Journal:  J Lipid Res       Date:  2008-06-25       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.